Suzhou Zelgen Biopharmaceuticals Co., Ltd. announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced operating loss was CNY 83.956 million compared to CNY 66.479 million a year ago. Net loss was CNY 79.712 million compared to CNY 62.262 million a year ago. Basic loss per share from continuing operations was CNY 0.33 compared to CNY 0.28 a year ago.